leadf
logo-loader
viewLexaGene Holdings Inc.

LexaGene announces first contract for MiQLab system by major biotech company

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to bring news the company has received a purchase order for the MiQLab system from a multinational biotechnology company that generates billions in annual revenue.

Regan says this company was looking to prevent massive product losses late in the manufacturing process and the company was looking for an easy to use and reliable sample-to-answer system. Regan said they found that with the MIQLab

Quick facts: LexaGene Holdings Inc.

Price: 1.26 CAD

TSX-V:LXG
Market: TSX-V
Market Cap: $143.28 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

LexaGene starts program to Identify UK and South African COVID Sequences

Lexagene Holdings (CVE: LXG- OTCQB: LXXGF) CEO Jack Regan joined Steve Darling from Proactive with news the company is planning to use their patented MiQLa system to investigate novel variants of the SARS-Cov-2 which is the pathogen that causes COVID-19. Dr. Regan telling Proactive this...

2 days, 3 hours ago

2 min read